Dr. Eric Lowry Cole, MD

Dr. Cole practices at Ambulatory Surgery Center at Berthelsen Main Campus in Houston, Texas.

Dr. Cole's NPI, 1295786960, was assigned on May 15, 2006. Dr. Cole graduated from Duke University School Of Medicine in 1992. Dr. Cole holds Texas license P0968.

Dr. Cole's primary practice is Ambulatory Surgery Center at Berthelsen Main Campus, at 2727 W Holcombe Blvd, Houston, TX 77025. The practice phone is (713) 442-3300.

Dr. Cole's primary practice is Ambulatory Surgery Center at Berthelsen Main Campus in Houston, Texas. The medical group on file is Kelsey-Seybold Clinic. Dmand AI also links Dr. Cole to 2 more medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cole practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Cole's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Cole is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Cole's licenses on file in 4 states: Texas, California, North Carolina and Virginia.

Dmand AI lists cancerous skin growth removal and head wound among the conditions Dr. Cole treats.

CMS data shows 11 Medicare services from Dr. Cole across 1 procedure code in 2024, all of them office visits, for 40 Medicare patients. Medicare paid $958 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 40 Medicare patients who saw Dr. Cole in 2024. The largest group is 65 to 74, with 22 patients. 73% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cole's median patient age at 48, with 51% women.

In 2024, Dr. Cole wrote 13 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $91 in total drug cost. In 2016, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Cole for performance year 2024, reported as part of a group. Dr. Cole accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Cole, published from 2014 to 2021. 2016 was the busiest year, with 2. The most frequent topics are Plastic Surgery Procedures, Surgical Flaps and Facial Muscles. Dr. Cole has published most often in Plast Reconstr Surg Glob Open. Dr. Cole's most frequent co-authors are Stefanos Boukovalas, MD, Richard F. Wagner, MD and Joshua Hays, MD.

CMS Open Payments shows 30 general payments to Dr. Cole from 15 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Baxter Healthcare paid the most, $301.

Dmand AI lists 2 awards for Dr. Cole, most recently CMS Stage 1 EHR in 2013.

Dr. Cole graduated from Duke University School Of Medicine in 1992. Dr. Cole is a member of ACS and ASPS.

Dr. Cole is in network with 23 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.